| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-85 |
Sentence |
denotes |
Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. |
| T1 |
0-85 |
Sentence |
denotes |
Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. |
| T2 |
86-217 |
Sentence |
denotes |
The expression of tissue factor (TF), the principal initiator of coagulation, is increased during inflammation and atherosclerosis. |
| T2 |
86-217 |
Sentence |
denotes |
The expression of tissue factor (TF), the principal initiator of coagulation, is increased during inflammation and atherosclerosis. |
| T3 |
218-283 |
Sentence |
denotes |
Both conditions are promoted by lysophosphatidylcholine (lysoPC). |
| T3 |
218-283 |
Sentence |
denotes |
Both conditions are promoted by lysophosphatidylcholine (lysoPC). |
| T4 |
284-447 |
Sentence |
denotes |
We observed in the present study that lysoPC (1 to 10 micromol/L) dose-dependently reduced TF activity in human monocytes, as elicited by lipopolysaccharide (LPS). |
| T4 |
284-447 |
Sentence |
denotes |
We observed in the present study that lysoPC (1 to 10 micromol/L) dose-dependently reduced TF activity in human monocytes, as elicited by lipopolysaccharide (LPS). |
| T5 |
448-572 |
Sentence |
denotes |
Lysophosphatidylethanolamine (lysoPE) and other lysophospholipids did not affect LPS-induced TF activity of human monocytes. |
| T5 |
448-572 |
Sentence |
denotes |
Lysophosphatidylethanolamine (lysoPE) and other lysophospholipids did not affect LPS-induced TF activity of human monocytes. |
| T6 |
573-641 |
Sentence |
denotes |
TF antigen expression as elicited by LPS was also lowered by lysoPC. |
| T6 |
573-641 |
Sentence |
denotes |
TF antigen expression as elicited by LPS was also lowered by lysoPC. |
| T7 |
642-780 |
Sentence |
denotes |
Phospholipid analyses indicated a selective increase in the lysoPC content of the monocytes after preincubation with the lysophospholipid. |
| T7 |
642-780 |
Sentence |
denotes |
Phospholipid analyses indicated a selective increase in the lysoPC content of the monocytes after preincubation with the lysophospholipid. |
| T8 |
781-874 |
Sentence |
denotes |
LysoPC inhibited the TF activity of Mono Mac-6 cells to a similar extent as in the monocytes. |
| T8 |
781-874 |
Sentence |
denotes |
LysoPC inhibited the TF activity of Mono Mac-6 cells to a similar extent as in the monocytes. |
| T9 |
875-986 |
Sentence |
denotes |
LPS binding to plasma membrane receptors and internalization of LPS into monocytes were not affected by lysoPC. |
| T9 |
875-986 |
Sentence |
denotes |
LPS binding to plasma membrane receptors and internalization of LPS into monocytes were not affected by lysoPC. |
| T10 |
987-1111 |
Sentence |
denotes |
In contrast, LPS-mediated nuclear binding of nuclear factor-kappaB/Rel to a TF-specific kappaB site was inhibited by lysoPC. |
| T10 |
987-1111 |
Sentence |
denotes |
In contrast, LPS-mediated nuclear binding of nuclear factor-kappaB/Rel to a TF-specific kappaB site was inhibited by lysoPC. |
| T11 |
1112-1206 |
Sentence |
denotes |
Induction of TF mRNA expression by LPS tended to be partially reduced by the lysophospholipid. |
| T11 |
1112-1206 |
Sentence |
denotes |
Induction of TF mRNA expression by LPS tended to be partially reduced by the lysophospholipid. |
| T12 |
1207-1265 |
Sentence |
denotes |
Preincubation with lysoPC increased monocytic cAMP levels. |
| T12 |
1207-1265 |
Sentence |
denotes |
Preincubation with lysoPC increased monocytic cAMP levels. |
| T13 |
1266-1422 |
Sentence |
denotes |
Inhibition of adenylyl cyclase by pretreatment with 2'-deoxy-3'-adenosine monophosphate partially reversed the inhibition of TF activity promoted by lysoPC. |
| T13 |
1266-1422 |
Sentence |
denotes |
Inhibition of adenylyl cyclase by pretreatment with 2'-deoxy-3'-adenosine monophosphate partially reversed the inhibition of TF activity promoted by lysoPC. |
| T14 |
1423-1605 |
Sentence |
denotes |
In conclusion, lysoPC markedly decreases LPS-mediated TF expression of human monocytes, the effect probably being mediated by both transcriptional and posttranscriptional mechanisms. |
| T14 |
1423-1605 |
Sentence |
denotes |
In conclusion, lysoPC markedly decreases LPS-mediated TF expression of human monocytes, the effect probably being mediated by both transcriptional and posttranscriptional mechanisms. |
| T15 |
1606-1698 |
Sentence |
denotes |
LysoPC may thus attenuate activation of coagulation during inflammation and atherosclerosis. |
| T15 |
1606-1698 |
Sentence |
denotes |
LysoPC may thus attenuate activation of coagulation during inflammation and atherosclerosis. |